243 related articles for article (PubMed ID: 29460133)
1. Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.
Xu C; Xu Y; Shen Z; Zhou H; Xiao J; Huang T
Int Urol Nephrol; 2018 Apr; 50(4):611-617. PubMed ID: 29460133
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.
Gong YM; Wang X; Liu S; Hu XC; Xu Y; Huang T
Int Urol Nephrol; 2022 Sep; 54(9):2125-2131. PubMed ID: 35691993
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 shows no effects on the prostatic index in high-fat-diet-fed rat with benign prostatic hyperplasia by improving insulin resistance.
Zheng JX; Xiao YC; Hu YR; Hao M; Kuang HY
Andrologia; 2015 Mar; 47(2):236-42. PubMed ID: 24605934
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits the proliferation of benign prostatic epithelial cells.
Wang Z; Xiao X; Ge R; Li J; Johnson CW; Rassoulian C; Olumi AF
PLoS One; 2017; 12(3):e0173335. PubMed ID: 28253329
[TBL] [Abstract][Full Text] [Related]
5. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
6. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
[TBL] [Abstract][Full Text] [Related]
7. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
Wu SF; Sun HZ; Qi XD; Tu ZH
Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
[TBL] [Abstract][Full Text] [Related]
8. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia.
Vikram A; Jena GB; Ramarao P
Prostate; 2010 Jan; 70(1):79-89. PubMed ID: 19790233
[TBL] [Abstract][Full Text] [Related]
9. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia.
Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V; Cherupanakkal C
Aging Male; 2018 Jun; 21(2):138-144. PubMed ID: 29129118
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.
Vikram A; Jena G; Ramarao P
Br J Pharmacol; 2010 Dec; 161(8):1708-21. PubMed ID: 20726985
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
14. Aerobic exercises ameliorate benign prostatic hyperplasia via IGF-1/IGF-1R/ERK/AKT signalling pathway in prostate tissue of high-fat-diet-fed mice with insulin resistance.
Nian L; Shukang G; Shasha W; Xiangyun L
Steroids; 2021 Nov; 175():108910. PubMed ID: 34461103
[TBL] [Abstract][Full Text] [Related]
15. Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective.
Mosli HH; Esmat A; Atawia RT; Shoieb SM; Mosli HA; Abdel-Naim AB
Sci Rep; 2015 Oct; 5():15639. PubMed ID: 26492952
[TBL] [Abstract][Full Text] [Related]
16. Prostatic fluid free insulin-like growth factor-1 in relation to benign prostatic hyperplasia: a controlled study.
Ceylan C; Serel A; Doluoglu OG; Armağan A; Yüksel S
Urol J; 2014 Jan; 10(4):1067-71. PubMed ID: 24469652
[TBL] [Abstract][Full Text] [Related]
17. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
Li W; Wu CL; Febbo PG; Olumi AF
Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
[TBL] [Abstract][Full Text] [Related]
18. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
[TBL] [Abstract][Full Text] [Related]
19. Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model.
Chen KC; Sung SY; Lin YT; Hsieh CL; Shen KH; Peng CC; Peng RY
BMC Urol; 2015 Nov; 15():113. PubMed ID: 26576637
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
